• 12 January 2018

    Billion-dollar deals mean bright future for Takeda

    Takeda has taken a massive step forward in its partnership and acquisition deals over the past year, totaling over a billion dollars. Their CEO, Christophe Weber, stated that the company’s...

  • 5 January 2018

    US pharma industry holds to price-cap pledge

    As part of a growing tradition, the new year coincides with a hike in US drug prices, with more than 30 drugs seeing an increase in price. However, after receiving...

  • 5 January 2018

    Glaucoma market: ten-year forecast

    The glaucoma market was valued at $2.6bn in 2016 and is expected to reach $3.8bn by the end of 2026 across the seven major markets.

  • 3 January 2018

    Seysara set to boost stagnant treatment landscape for acne

    On 20 December, Allergan and Paratek Pharmaceuticals announced that the FDA accepted a New Drug Application (NDA) to review Seysara (sarecycline) for the treatment of moderate-to-severe acne vulgaris in patients...